Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Indivior PLC (INDV) has a market cap of $1.50 billion USD. According to our data, Indivior PLC is ranked No.4579 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $1.50 B |
-2.97%
|
| Dec 31, 2024 | $1.55 B |
-18.60%
|
| Dec 29, 2023 | $1.90 B |
-29.79%
|
| Dec 30, 2022 | $2.71 B |
530.43%
|
| Dec 31, 2021 | $0.43 B |
135.49%
|
| Dec 31, 2020 | $0.18 B |
181.73%
|
| Dec 31, 2019 | $64.81 M |
-61.48%
|
| Dec 31, 2018 | $0.17 B |
-75.45%
|
| Dec 29, 2017 | $0.69 B |
54.90%
|
| Dec 30, 2016 | $0.44 B |
30.51%
|
| Dec 31, 2015 | $0.34 B |
20.89%
|
| Dec 31, 2014 | $0.28 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
 Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
 Viatris
VTRS
|
$13.30 B |
-0.000 M
|
USA
|
 Jazz Pharmaceuticals
JAZZ
|
$7.31 B |
0.000 M
|
Ireland
|
 Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
 Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
 AbbVie
ABBV
|
$298.91 B |
0.013 M
|
USA
|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
| Market Cap | = | INDV Stock Price | * | INDV Shares Outstanding |
| = | $12.08 | * | 0.12 B | |
| = | $1.50 B |